Clinical dermatology company Sienna Biopharmaceuticals closes second Series A financing

July 19, 2016
Dermatology and aesthetics technology company Sienna Biopharmaceuticals has completed a second closing of its Series A financing.

Sienna Biopharmaceuticals (Westlake Village, CA), a clinical stage company that focuses on dermatology and aesthetics, has completed a second closing of its Series A financing, securing an additional $12 million in equity capital and bringing the total capital raised to approximately $46 million.

The company is developing novel approaches to treat skin based on plasmonic resonance, originally developed at Sienna Labs (Carlsbad, CA) under the leadership of Todd Harris, Ph.D. The technology, called Silver Plasmonic Therapy (SPT), entails using a proprietary topical solution containing patented plasmonic particles that interact with the light emitted by existing medical laser systems, allowing controlled targeting of microstructures in the skin. The company believes the treatment has the potential to meet unmet needs in the areas of acne, hair removal, and potentially other areas.

The additional investment proceeds are targeted to fund the company's pharmaceutical research and advance its business development efforts. Clinical trials are already underway and the company is evaluating additional potential indications.

For more information, please visit www.siennabio.com.

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025
Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025
To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025
In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025
In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!